Walleye Capital’s Xeris Biopharma Holdings XERS Stock Holding History
Bought
Maintained
Sold
Other funds holding XERS
Walleye Capital's XERS Position: Q3 2026 in Review
Walleye Capital sold out of Xeris Biopharma Holdings (XERS) in Q3 2026, closing a stake of 611,296 shares — an estimated $4.84M sold.
Walleye Capital first reported a position in XERS in Q1 2020 and held it in 8 quarters. The position peaked at $5.08M in Q3 2025. 249 funds tracked by Wall St. Rank hold XERS as of Q3 2026.
- Walleye Capital reported no remaining Xeris Biopharma Holdings position as of Q3 2026 after selling out during the quarter.
- Walleye Capital sold 611,296 Xeris Biopharma Holdings shares in Q3 2026, an estimated $4.84M.
- Walleye Capital first reported a position in Xeris Biopharma Holdings in Q1 2020 and held it in 8 quarters.
- Walleye Capital's Xeris Biopharma Holdings position peaked at $5.08M in Q3 2025.
- 249 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q3 2026.
Based on Walleye Capital's 13F filing for Q3 2026, filed 13 Nov 2026.